Deals

In less than 60 days since the beginning of the discussions, we have negotiated and finalized a financing agreement to back the acquisition, in a very difficult market environment.
Cosimo Vitola, Managing Partner, Ethica Corporate Finance SpA

Completion Date
December 2009

Transaction Type
Acquisition

Transaction Value
(Not disclosed)

Lead Partner
Cosimo Vitola
Telephone +39 02 92 88 04 00

Background
Ethica Corporate Finance acted as sole advisor to Mediolanum Farmaceutici in the acquisition of Neopharmed from Merck.

Mediolanum farmaceutici S.p.A. engages in the discovery, development, and marketing of pharmaceuticals/therapeutics products and prescription drugs. It serves therapeutic target areas, including allergy, cardiovascular, and infectious diseases. The company was founded in 1972 and is based in Milan, Italy. Mediolanum farmaceutici S.p.A. operates as a subsidiary of Mediolanum farmaceutici Group.

What Difference Did We Make?
We have advised Mediolanum in negotiating the purchase agreement and, at the same time, we have identified a pool of lenders to finance the acquisition and have negotiated the financing agreement. We have also helped our client structuring a business plan to support negotiations.